Capital Investment Counsel, Inc Gilead Sciences, Inc. Transaction History

Capital Investment Counsel, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 27, 2021	SELL	$63.47 - $69.35 $216,496 - $236,552	-3,411 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$60.0 - $68.46 $204,660 - $233,517	3,411 New	3,411 $220,000
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $201,730 - $229,862	-3,561 Closed	0 $0
Q3 2020 Oct 19, 2020	BUY	$62.1 - $78.08 $15,525 - $19,520	250 Added 7.55%	3,561 $225,000
Q2 2020 Aug 04, 2020	BUY	$72.34 - $84.0 $239,517 - $278,124	3,311 New	3,311 $255,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, Inc, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Counsel, Inc with notifications on news.